Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D001842:Bone and Bones / Q000378:metabolism; D002116:Calcitonin / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D002118:Calcium / Q000097:blood / Q000652:urine; D002302:Cardiac Output / Q000187:drug effects; D003404:Creatinine / Q000652:urine; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000378:metabolism; D010710:Phosphates / Q000008:administration & dosage / Q000097:blood; D012964:Sodium / Q000652:urine
D010710:Phosphates; D002116:Calcitonin; D012964:Sodium; D003404:Creatinine; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium